Milk Proteins and Micronutrient Supplementation in Obese Children
NCT ID: NCT04319419
Last Updated: 2020-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
152 participants
INTERVENTIONAL
2011-12-05
2012-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective was to evaluate a supplement with milk proteins and multivitamins and minerals with nutrition education on anthropometry, body composition, micronutrient status, blood pressure, lipid profile, systemic inflammation, leptin and insulin resistance in obese children at baseline and after 6 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a School-based Obesity Prevention Program in Mexican Schoolchildren: Cluster Randomized Controlled Trial
NCT05461703
Lifestyle Interventions and Metabolic Profile in Obese Children
NCT03728621
Role of Dietary Protein on Satiety, Food Intake and Thermic Effect of Food
NCT02200796
The Acute Effect of Exercise on Appetite Appetite-regulating Hormones and Inflammation in Children
NCT02619461
Nutrition and Soccer for Pediatric Overweight and Obesity
NCT00365651
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Children in both groups were evaluated at baseline and 6 months after treatment initiated. At both times the following variables were evaluated:
Visit 1 (Screening): Mothers and parents received oral and written information regarding all aspects of the study. Informed consent, medical history, demographic information, weight and height were obtained.
Visit 2 (Clinical Laboratory testing): A blood preasure and sample was taken by an specialist. Blood test included Glucose, total cholesterol, triglycerides, HDL cholesterol and LDL cholesterol, Tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10), C reactive protein, insulin and leptin.
Visit 3 (Nutrition Clinic at UAQ): body composition was determined by DEXA. The NE were given at Nutrition Clinic and school to the children's parents each week.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supplement with micronutrients
Nutrition education with a supplement
Supplement with micronutrients
Obese children were divided in 2 groups. A group received the supplement plus nutrition education and other group was a control, only received nutrition education.
Nutrition education
Group received only nutrition education
Nutrition education
Group received nutrition education program during 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supplement with micronutrients
Obese children were divided in 2 groups. A group received the supplement plus nutrition education and other group was a control, only received nutrition education.
Nutrition education
Group received nutrition education program during 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged: 6 to 11 years
* Both sex
* Parents accepted to participate and signed informant consent
Exclusion Criteria
* Metabolic disease
* Hypertension
* Physical disability
* Using vitamins and minerals supplements and/or receiving treatment for obesity during the last 3 months.
6 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NUCITEC S.A. de C.V.
UNKNOWN
Universidad Autonoma de Queretaro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jorge Luis Rosado Loria
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FNN201104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.